Skip to content

EMBLEM MRI S-ICD Model 219, Subcutaneous-Implantable… recallZ-3038-2017 · Boston Scientific Corporation · initiated Jun 29, 2017

Class II Terminated All recalls posted in August 2017

Is my device affected?

  1. Compare the model, catalog and lot or serial numbers on your device or its packaging with the code information below. A recall usually covers only specific models or lots.
  2. If yours is listed, follow the instructions from Boston Scientific Corporation or your healthcare provider. The company's action is summarized under what the company is doing.
  3. Do not stop using a prescribed or implanted device on your own — talk to your healthcare provider first.

Where to find your model and lot numbers · What recall classes and statuses mean

Why it was recalled

The device can deliver an atypical amount of energy due to memory corruption inside the device.

FDA root cause category: Software design

What the company is doing

The firm issued notifications dated June, 2017, beginning 6/29/2017 to physicians (implanting and patient follow-up physicians) via hand delivery by their sales representatives. The firm estimated approximately 30% of the U.S. physicians would be receiving the notification via hand delivery. Hand delivery by affiliates in foreign countries to customers began approximately 6/30/2017. Overnight mail letters were issued to the U.S. and foreign physicians starting on/about 7/7/2017 who did not receive hand- delivered notifications.

Recall details

Recall number
Z-3038-2017
Recall class
Class II
Status
Terminated
Initiated by the company
Jun 29, 2017
Posted by the FDA
Aug 16, 2017
Recalling firm
Boston Scientific Corporation
Quantity
Approximately 9,200 devices
Product code
LWS
FDA submissions
P110042
Distribution
Worldwide - US Nationwide distribution, including Puerto Rico, U.S. Virgin Island, and Guam, There was also worldwide foreign distribution, including Canada.

Product description

EMBLEM MRI S-ICD Model 219, Subcutaneous-Implantable Cardioverter Defibrillator, Rx. Product Usage: The S-ICD system is intended to provide defibrillation therapy for the treatment of life-threatening ventricular tachyarrhythmias in patients who do not have symptomatic bradycardia, incessant ventricular tachycardia, or spontaneous, frequently recurring ventricular tachycardia that is reliably terminated with anti-tachycardia pacing

Code information (models, lots, serial numbers)

All serial numbers

Other devices under the same FDA submission

10 devices cleared under P110042 — the recall does not name any of them by identifier. One submission often covers many models, so they may or may not be affected.

Other products in the same recall event

The FDA groups related products into one recall event (event 77803).

Sources and updates

How recalls are matched to devices · Editorial policy · Report an error on this page